[go: up one dir, main page]

AU2867784A - Aircraft undercarriage assemblies - Google Patents

Aircraft undercarriage assemblies

Info

Publication number
AU2867784A
AU2867784A AU28677/84A AU2867784A AU2867784A AU 2867784 A AU2867784 A AU 2867784A AU 28677/84 A AU28677/84 A AU 28677/84A AU 2867784 A AU2867784 A AU 2867784A AU 2867784 A AU2867784 A AU 2867784A
Authority
AU
Australia
Prior art keywords
aircraft undercarriage
undercarriage assemblies
assemblies
aircraft
undercarriage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28677/84A
Inventor
Sinclair Graham Roger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2867784A publication Critical patent/AU2867784A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/55IL-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/56IFN-alpha
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/57IFN-gamma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU28677/84A 1983-05-12 1984-05-14 Aircraft undercarriage assemblies Abandoned AU2867784A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPF9305 1983-05-12
AUPF9356 1983-05-16
PCT/JP1984/000085 WO1985003934A1 (en) 1984-03-06 1984-03-06 Chemically modified protein and process for its preparation

Publications (1)

Publication Number Publication Date
AU2867784A true AU2867784A (en) 1984-12-04

Family

ID=13818260

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28677/84A Abandoned AU2867784A (en) 1983-05-12 1984-05-14 Aircraft undercarriage assemblies

Country Status (5)

Country Link
US (1) USH1662H (en)
JP (2) JPH0676439B2 (en)
KR (1) KR920007681B1 (en)
AU (1) AU2867784A (en)
WO (2) WO1985003934A1 (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3676670D1 (en) * 1985-06-26 1991-02-07 Cetus Corp SOLUBILIZATION OF PROTEINS FOR PHARMACEUTICAL COMPOSITIONS BY POLYMER CONJUGATION.
US5214131A (en) * 1988-05-06 1993-05-25 Sumitomo Pharmaceuticals Company, Limited Polyethylene glycol derivatives, modified peptides and production thereof
GB8824591D0 (en) * 1988-10-20 1988-11-23 Royal Free Hosp School Med Fractionation process
US5349052A (en) * 1988-10-20 1994-09-20 Royal Free Hospital School Of Medicine Process for fractionating polyethylene glycol (PEG)-protein adducts and an adduct for PEG and granulocyte-macrophage colony stimulating factor
US5342940A (en) * 1989-05-27 1994-08-30 Sumitomo Pharmaceuticals Company, Limited Polyethylene glycol derivatives, process for preparing the same
FR2675807B1 (en) * 1991-04-23 1994-07-01 Medgenix Group Sa CONJUGATE OF CALCITONIN AND POLYETHYLENE GLYCOL.
US5382657A (en) * 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
US5359030A (en) * 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
DE69800640T2 (en) * 1997-01-29 2001-07-05 Polymasc Pharmaceuticals Plc, London PEGYLATION PROCEDURE
WO2002014504A1 (en) 2000-08-11 2002-02-21 Kirin Beer Kabushiki Kaisha Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
ATE441666T1 (en) 2001-12-28 2009-09-15 Kyowa Hakko Kirin Co Ltd ANTIBODIES AGAINST FIBROBLAST GROWTH FACTOR 23
BRPI0306993B8 (en) * 2002-01-18 2021-05-25 Biogen Idec Inc activated polyalkylene glycol polymer; composition; and use of a compound in the production of a drug for the treatment of multiple sclerosis or susceptible viral infection.
JP2006519170A (en) * 2002-12-26 2006-08-24 マウンテン ビュー ファーマシューティカルズ,インコーポレイテッド Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones, and their antagonists with conserved receptor binding activity
CN102319437B (en) 2002-12-26 2017-10-13 山景医药公司 Polymer conjugates of interferon-beta with enhanced biological utility
PT1666496E (en) 2003-08-25 2014-06-24 Toray Industries Interferon-beta composite
EP1676862B1 (en) 2003-09-24 2010-12-22 Kyowa Hakko Kirin Co., Ltd. Recombinant antibody against human insulin-like growth factor
US20080199423A1 (en) * 2004-06-18 2008-08-21 Genentech, Inc. Methods of Using Apo2l Receptor Agonists and Ink Cell Activators
AU2005266892B2 (en) * 2004-07-29 2011-03-03 Bristol-Myers Squibb Company Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
WO2006080171A1 (en) 2005-01-31 2006-08-03 Effector Cell Institute, Inc. Immunopotentiating agent
EP1959009A4 (en) 2005-12-06 2010-04-28 Kyowa Hakko Kirin Co Ltd GENETICALLY RECOMBINANT ANTI-PERP ANTIBODY
EP1997504A1 (en) * 2006-03-01 2008-12-03 Keio University Novel antithrombotic agent
US7883705B2 (en) 2007-02-14 2011-02-08 Kyowa Hakko Kirin Co., Ltd. Anti FGF23 antibody and a pharmaceutical composition comprising the same
WO2008114733A1 (en) 2007-03-16 2008-09-25 Kyowa Hakko Kirin Co., Ltd. Anti-claudin-4 antibody
WO2009072628A1 (en) 2007-12-05 2009-06-11 Kyowa Hakko Kirin Co., Ltd. Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
KR20110039220A (en) 2008-06-30 2011-04-15 교와 핫꼬 기린 가부시키가이샤 Anti-CD27 antibody
KR20110031469A (en) 2008-07-17 2011-03-28 교와 핫꼬 기린 가부시키가이샤 Antibody Asc Amino Acid Transporter 2 (ASCT2) Antibody
JP5511686B2 (en) 2008-12-26 2014-06-04 協和発酵キリン株式会社 Anti-CD4 antibody
PL2423228T3 (en) 2009-04-20 2016-06-30 Kyowa Hakko Kirin Co Ltd Antibody containing igg2 having amino acid mutation introduced therein
EP2543727B1 (en) 2010-03-02 2016-08-31 Kyowa Hakko Kirin Co., Ltd. Modified antibody composition
PT2581113T (en) 2010-06-11 2018-07-04 Univ Kyushu Nat Univ Corp Anti-tim-3 antibody
AU2012274461A1 (en) 2011-06-20 2014-01-16 Kyowa Hakko Kirin Co., Ltd. Anti-erbB3 antibody
HK1209769A1 (en) 2012-07-02 2016-04-08 Kyowa Hakko Kirin Co., Ltd. Therapeutic agent for anemia including renal anemia and cancer-induced anemia which contains anti-bmp9 antibody as active ingredient
TWI614266B (en) 2012-12-07 2018-02-11 協和醱酵麒麟有限公司 anti-FOLR1 antibody
US11912775B2 (en) 2017-07-18 2024-02-27 Kyowa Kirin Co., Ltd. Anti-human CCR1 monoclonal antibody
EP3708589A4 (en) 2017-11-08 2021-08-11 Kyowa Kirin Co., Ltd. BISPECIFIC ANTIBODIES THAT BIND TO CD40 AND EpCAM
JP7323456B2 (en) 2017-12-12 2023-08-08 協和キリン株式会社 ANTI-BMP10 ANTIBODY AND THERAPEUTIC AGENT FOR HYPERTENSION AND HYPERTENSIVE DISEASE CONTAINING THE ANTIBODY AS AN ACTIVE INGREDIENT
MX2021007797A (en) 2018-12-28 2021-10-26 Kyowa Kirin Co Ltd BIASPECIFIC ANTIBODY THAT BINDS TO THE TRANSFERRIN RECEPTOR (TFR).
US12466891B2 (en) 2019-05-15 2025-11-11 Kyowa Kirin Co., Ltd. Bispecific antibody binding to CD40 and GPC3
CN113891728A (en) 2019-05-15 2022-01-04 协和麒麟株式会社 Bispecific antibodies that bind to CD40 and FAP
CA3229748A1 (en) 2021-08-26 2023-03-02 Akifumi Kato Bispecific antibody that binds to cd116 and cd131
WO2023153471A1 (en) 2022-02-09 2023-08-17 国立研究開発法人医薬基盤・健康・栄養研究所 Antibody or fragment thereof that binds to fcrl1
TW202413406A (en) 2022-08-10 2024-04-01 日商協和麒麟股份有限公司 Anti-FGF23 antibody, and fragment of said antibody

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2433883C2 (en) * 1973-07-20 1986-03-27 Research Corp., New York, N.Y. Use of physiologically active polypeptides
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4002531A (en) 1976-01-22 1977-01-11 Pierce Chemical Company Modifying enzymes with polyethylene glycol and product produced thereby
DE2930542A1 (en) * 1979-07-27 1981-02-12 Hoechst Ag NEW INSULINE DERIVATIVES AND METHOD FOR THEIR PRODUCTION
JPS57118789A (en) * 1981-01-13 1982-07-23 Eisai Co Ltd Modified streptokinase and its preparation
JPS57192435A (en) * 1981-05-20 1982-11-26 Toyobo Co Ltd Modified polypeptide
JPS58154596A (en) * 1982-03-09 1983-09-14 Toray Ind Inc Modification of interferon

Also Published As

Publication number Publication date
KR850006875A (en) 1985-10-21
JPH0696599B2 (en) 1994-11-30
WO1985003934A1 (en) 1985-09-12
JPH0676439B2 (en) 1994-09-28
USH1662H (en) 1997-07-01
WO1985003868A1 (en) 1985-09-12
KR920007681B1 (en) 1992-09-14
JPS60226821A (en) 1985-11-12
JPS61178926A (en) 1986-08-11

Similar Documents

Publication Publication Date Title
AU2867784A (en) Aircraft undercarriage assemblies
AU563208B2 (en) Aircraft seat
GB2145049B (en) Tandem or multi-winged aircraft
DE3469289D1 (en) Landing aid for helicopter
AU91013S (en) An aeroplane
EP0174147A3 (en) Airplane tyre
AU547328B2 (en) Aircraft ground proximity warning
AU3301984A (en) Business form assemblies
AU3396384A (en) Boride-alumina composite
AU579046B2 (en) Panel assemblies and methods for making the same
AU2700484A (en) Composite structure
AU571006B2 (en) Business form assemblies
GB8421988D0 (en) Aircraft
GB2134059B (en) Composite helicopter fuselage
DE3460387D1 (en) Cabin
AU3749485A (en) Menetelma ja laitteisto veden jaatymislammon hyvaksikayttamiseksilampopumpun lammonlahteena
GB2134462B (en) An aircraft undercarriage
GB2168812B (en) Aircraft landing aid
GB2075448B (en) Aircraft undercarriage unit
GB2146603B (en) Auxiliary wings for rotary-winged aircraft
EP0116657A3 (en) Aircraft retractable undercarriage
GB2143483B (en) Compound helicopter and powerplant therefor
AU3271984A (en) Aircraft cabin management terminal
AU578763B2 (en) Log cabin
PL236360A2 (en) Aircraft undercarriage